Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Alexander S, Ault K, Babcock H, Baker C, Bhat N, Bridges C, Brinker K, Broder K, Callaghan W, Chambers C, Cheatham J, Cragan J, Fraser M, Friedman J, Gilbert M, Hocevar S, Iwamoto M, Johnson-James T, Kacica M, Lawrence R, Marks D, Mersereau P, Mitchell A, Moro P, Mosby L, Munoz F, Newsome K, Olson CK, Omer SB, Peacock G, Pursley D, Revzina N, Riley LE, Ruhl C, Shealy K, Sheffield J, Snider D, Tepper N, Way SH, Weinbaum C, Zotti M.
Division of Birth Defects and Developmental Disabilities, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Pregnant women and their newborn infants are at increased risk for influenza-associated complications, based on data from seasonal influenza and influenza pandemics. The Centers for Disease Control and Prevention (CDC) developed public health recommendations for these populations in response to the 2009 H1N1 pandemic. A review of these recommendations and information that was collected during the pandemic is needed to prepare for future influenza seasons and pandemics. The CDC convened a meeting entitled "Pandemic Influenza Revisited: Special Considerations for Pregnant Women and Newborns" on August 12-13, 2010, to gain input from experts and key partners on 4 main topics: antiviral prophylaxis and therapy, vaccine use, intrapartum/newborn (including infection control) issues, and nonpharmaceutical interventions and health care planning. Challenges to communicating recommendations regarding influenza to pregnant women and their health care providers were also discussed. After careful consideration of the available information and individual expert input, the CDC updated its recommendations for these populations for future influenza seasons and pandemics.
Published by Mosby, Inc.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on